SMMT
Summit Therapeutics PLC
15.60$
-4.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Summit Therapeutics PLC (SMMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -240 million GBP. Tick rows to compare them in a chart.
All figures in millions of GBP.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.1 | 0.0 | -0.9 | -6.0 | -16 | -15 | -2.6 | -4.3 | -3.8 | -5.0 | -9.7 | -17 | -24 | 15 | -21 | -35 | -27 | -35 | -54 | -34 | -61 | -114 | -240 | |
| 0.0 | 0.0 | 0.2 | 0.7 | 3.3 | 2.7 | 3.8 | 0.7 | 0.3 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.6 | 2.0 | 1.4 | 1.5 | 1.8 | 1.0 | 0.2 | 0.1 | 0.1 | |
| – | 0.1 | 0.1 | 0.8 | 1.0 | 0.3 | 0.0 | 0.1 | 0.1 | 0.2 | 0.4 | 1.4 | 1.7 | 1.7 | 2.3 | 6.3 | 0.5 | 1.3 | 9.5 | 9.7 | 11 | 41 | 544 | |
| – | – | – | – | – | – | – | – | – | – | -0.2 | 2.2 | 2.2 | 1.6 | 0.3 | 3.6 | 4.5 | 4.6 | 14 | 26 | – | – | – | |
| 0.0 | 0.2 | 0.3 | 0.8 | 2.2 | 16 | 1.0 | 3.6 | 0.0 | 0.1 | 0.7 | -0.7 | 1.1 | 40 | 6.9 | -55 | 1.0 | 0.5 | 0.0 | 8.0 | -0.4 | 12 | 23 | |
| 0.0 | 0.0 | 2.5 | 3.4 | 3.9 | 1.7 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.7 | 0.2 | 0.3 | 0.3 | 0.2 | 0.5 | 0.1 | 0.1 | 0.5 | |
| – | 0.0 | -1.4 | -2.3 | -1.5 | -1.2 | -0.1 | -0.2 | -0.2 | -0.1 | 0.1 | 0.0 | -0.1 | -0.1 | -7.4 | -0.3 | -0.1 | -0.3 | -0.2 | -0.5 | -465 | -164 | -129 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 4.7 | 31 | 1,000,000,000,000 | 1,000,000,000,000 | 1,000,000,000,000 | 0.0 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -0.3 | -0.3 | 0.0 | 0.0 | -0.1 | -0.3 | -0.4 | 520 | 520 | 520 | -25 | -100 | 0.0 | |
| 0.1 | 26 | 1.4 | 19 | 1.3 | 5.3 | 8.1 | 0.0 | 2.1 | 7.2 | 7.4 | 30 | 32 | 0.5 | 19 | 45 | 33 | 37 | 58 | 506 | 68 | 305 | 458 | |
| 0.2 | -26 | -20 | 11 | -16 | -11 | 5.4 | -4.5 | -1.8 | 2.1 | -2.2 | 14 | 7.2 | 15 | -11 | 6.8 | 6.8 | 1.9 | 4.0 | 470 | -457 | 27 | 89 | |
| -0.1 | 0.0 | -4.1 | -9.3 | -20 | -16 | -2.8 | -4.5 | -4.0 | -5.2 | -9.8 | -17 | -25 | 15 | -21 | -35 | -16 | -36 | -54 | -34 | -61 | -114 | -240 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.